Daré Bioscience Reports Second Quarter 2026 Results and Highlights Commercial Inflection as Multi-Product Women’s Health Strategy Advances
Go back to Daré Bioscience Reports Second Quarter 2026 Results and Highlights Commercial Inflection as Multi-Product Women’s Health Strategy Advances| (NASDAQ: DARE) | Delayed: 0.71 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.71 | 52 Week High | $ | |||
| Open | $0.71 | 52 Week Low | $ | |||
| Day High | $0.71 | P/E | N/A | |||
| Day Low | $0.71 | EPS | $ | |||
| Volume | 9,250 | |||||
| (NASDAQ: DARE) | Delayed: 0.71 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.71 | 52 Week High | $ | |||
| Open | $0.71 | 52 Week Low | $ | |||
| Day High | $0.71 | P/E | N/A | |||
| Day Low | $0.71 | EPS | $ | |||
| Volume | 9,250 | |||||

